Pharmaceutical Approval Update.

By Freedom WaresSeptember 7, 2018No Comments

Home » Pharmaceutical Approval Update.

2018 Sep;43(9):528-530.

Abstract

Baricitinib (Olumiant) tablets for rheumatoid arthritis; plazomicin (Zemdri) injection for complicated urinary tract infections; and cannabidiol (Epidiolex) oral solution for seizures with Lennox-Gastaut syndrome and Dravet syndrome.

PMID: 30186023

Freedom Wares

Previous PostCellular localization and regulation of receptors and enzymes of the endocannabinoid system in intestinal and systemic inflammation.
Next PostCharacterization of an acidic α-galactosidase from hemp (Cannabis sativa L.) seeds and its application in removal of raffinose family oligosaccharides (RFOs).

Pharmaceutical Approval Update.

Abstract

Freedom Wares

Previous PostCellular localization and regulation of receptors and enzymes of the endocannabinoid system in intestinal and systemic inflammation.

Next PostCharacterization of an acidic α-galactosidase from hemp (Cannabis sativa L.) seeds and its application in removal of raffinose family oligosaccharides (RFOs).